Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country

Muntañola, Ana; Hernández‑Rivas,  José Ángel; Alonso, Rosalía; Mirás, Fátima; Osorio, Santiago; Crespo Maull, Marta; Sánchez Montalvá, Adrián; Ruiz Camps, Isabel; Abrisqueta Costa, Pablo; Bosch Albareda, Francesc; Villacampa Javierre, Guillermo

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Muntañola, Ana
dc.contributor.author	Hernández‑Rivas, José Ángel
dc.contributor.author	Alonso, Rosalía
dc.contributor.author	Mirás, Fátima
dc.contributor.author	Osorio, Santiago
dc.contributor.author	Crespo Maull, Marta
dc.contributor.author	Sánchez Montalvá, Adrián
dc.contributor.author	Ruiz Camps, Isabel
dc.contributor.author	Abrisqueta Costa, Pablo
dc.contributor.author	Bosch Albareda, Francesc
dc.contributor.author	Villacampa Javierre, Guillermo
dc.date.accessioned	2021-09-10T11:46:18Z
dc.date.available	2021-09-10T11:46:18Z
dc.date.issued	2020-12-18
dc.identifier.citation	Muntañola A, Villacampa G, Hernández-Rivas JÁ, Alonso R, Mirás F, Osorio S, et al. Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country. Exp Hematol Oncol. 2020 Dec 18;9:37.
dc.identifier.issn	2162-3619
dc.identifier.uri	https://hdl.handle.net/11351/6302
dc.description	Infecció per SARS-CoV-2; Leucèmia limfocítica crònica
dc.language.iso	eng
dc.publisher	BMC
dc.relation.ispartofseries	Experimental Hematology & Oncology;9
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	COVID-19 (Malaltia)
dc.subject	Leucèmia limfocítica crònica
dc.subject	Mortalitat
dc.subject.mesh	Coronavirus Infections
dc.subject.mesh	Leukemia, Lymphocytic, Chronic, B-Cell
dc.subject.mesh	Mortality
dc.title	Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
dc.type	info:eu-repo/semantics/other
dc.identifier.doi	10.1186/s40164-020-00195-x
dc.subject.decs	infecciones por Coronavirus
dc.subject.decs	leucemia linfocítica crónica de células B
dc.subject.decs	mortalidad
dc.relation.publishversion	https://ehoonline.biomedcentral.com/articles/10.1186/s40164-020-00195-x
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Muntañola A] Hospital Universitari Mútua Terrassa, Barcelona, Spain. [Villacampa G] Oncology Data Science, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Hernández-Rivas JÁ] Hospital Universitario Infanta Leonor, Madrid, Spain. [Alonso R] Hospital Universitario Puerta de Hierro, Madrid, Spain. [Mirás F] Hospital Universitario 12 de Octubre, Madrid, Spain. [Osorio S] Hospital Universitario Gregorio Marañón/Gregorio Marañón Health Institute (IiSGM), Madrid, Spain. [Crespo M, Sánchez MJ, Ruiz-Camps I, Abrisqueta P, Bosch F] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid	33339537
dc.identifier.wos	000600115300001
dc.rights.accessrights	info:eu-repo/semantics/openAccess